{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:57:53Z","timestamp":1767769073990,"version":"3.48.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioinform."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The majority of available transcriptomics-related cancer prognosis studies strive to define one collection of biomarkers that can be used to predict high-risk patients. However, using a single biomarker profile could restrict its strength and applicability to diverse groups of patients. In order to fill this gap, we discuss the prospect of determining several, discrete sets of prognostic biomarkers in Skin Cutaneous Melanoma (SKCM). Our search identifies various genes including CREG1, PCGF5 and VPS13C whose expression pattern depicts significant correlations with overall survival (OS) in SKCM patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We developed machine learning-based prognostic models using SKCM gene expression data to predict 1-, 3-, and 5-year overall survival. Advanced feature selection approaches were applied to identify prognostic biomarkers. The primary biomarker set consisted of 20 genes selected using state-of-the-art feature selection techniques. Machine learning classifiers were trained to distinguish high-risk from low-risk patients using these biomarkers. The process was systematically repeated to identify seven independent biomarker sets, each containing 20 unique genes without overlap. Model performance was evaluated using AUC and Cohen's Kappa metrics on an independent test dataset. Validation was further performed using the GEO dataset GSE65904, employing subsets of biomarkers from the primary and third sets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The primary biomarker-based prognostic model demonstrated strong predictive ability, achieving an AUC of 0.90 and a Kappa of 0.58 in identifying high-risk SKCM patients. A second independent 20-gene set, with no overlap with the first, produced an AUC of 0.89 and Kappa of 0.56. Across all seven biomarker sets, performance ranged from 0.84 to 0.91 (AUC) and 0.48 to 0.64 (Kappa). Notably, the fifth biomarker set yielded the highest performance with an AUC of 0.91 and Kappa of 0.64. External validation confirmed the predictive utility of selected biomarkers where genes from the primary set achieved an AUC of 0.83 on GSE65904. While genes from the third set achieved an AUC of 0.86 on the same dataset.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      Our results show that only one gene-expression signature is not sufficient to predict SKCM prognosis. Alternatively, high-risk patients can be accurately predicted using multiple independent biomarker sets providing flexibility in both clinical and computational practices. The high similarity in the results of all seven sets (AUC 0.84-0.91; Kappa 0.48-0.64) signifies the stability and strength of the method. The external validation of these biomarkers with GEO data also helps to confirm the reliability of these biomarkers and hints at their potential wider applicability. This work facilitates transparency by ensuring that all the data and code is publicly accessible (\n                      <jats:ext-link>https:\/\/github.com\/raghavagps\/skcm_prognostic_biomarker<\/jats:ext-link>\n                      ), which also promotes future developments in creating multi-signature prognostic tools in melanoma.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fbinf.2025.1624329","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:53:14Z","timestamp":1767768794000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of multiple prognostic biomarker sets for risk stratification in SKCM"],"prefix":"10.3389","volume":"5","author":[{"given":"Shivani","family":"Malik","sequence":"first","affiliation":[]},{"given":"Ritu","family":"Tomer","sequence":"additional","affiliation":[]},{"given":"Akanksha","family":"Arora","sequence":"additional","affiliation":[]},{"given":"Gajendra P. S.","family":"Raghava","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e100683","DOI":"10.1371\/journal.pone.0100683","article-title":"Assessment of PALB2 as a candidate melanoma susceptibility gene","volume":"9","author":"Aoude","year":"2014","journal-title":"PLoS One"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1101\/2024.09.04.611306","article-title":"A graph curvature-based pipeline for discovering immune checkpoint response biomarkers","author":"Bannon","year":"2024","journal-title":"bioRxiv"},{"key":"B3","doi-asserted-by":"publisher","first-page":"15790","DOI":"10.1038\/s41598-019-52134-4","article-title":"Prediction and analysis of skin cancer progression using genomics profiles of patients","volume":"9","author":"Bhalla","year":"2019","journal-title":"Sci. Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41420-023-01513-y","article-title":"The TLR3 L412F polymorphism prevents TLR3-mediated tumor cell death induction in pediatric sarcomas","volume":"9","author":"Bisaccia","year":"2023","journal-title":"Cell death Discov."},{"key":"B5","doi-asserted-by":"publisher","first-page":"D1227","DOI":"10.1093\/nar\/gkad1040","article-title":"DGIdb 5.0: rebuilding the drug-gene interaction database for precision medicine and drug discovery platforms","volume":"52","author":"Cannon","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/diagnostics9020059","article-title":"Expressions of HLA class II genes in cutaneous melanoma were associated with clinical outcome: bioinformatics approaches and systematic analysis of public microarray and RNA-seq datasets","volume":"9","author":"Chen","year":"2019","journal-title":"Diagn. Basel, Switz."},{"key":"B7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/pcmr.12919","article-title":"Analysis of CRISPR-Cas9 screens identifies genetic dependencies in melanoma","volume":"34","author":"Christodoulou","year":"2021","journal-title":"Pigment. Cell Melanoma Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12863-018-0633-8","article-title":"Using recursive feature elimination in random forest to account for correlated variables in high dimensional data","volume":"19","author":"Darst","year":"2018","journal-title":"BMC Genet."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2142569\/v1","article-title":"MYL2 is a potential diagnostic, prognostic, and immune biomarker for HNSC","author":"Ding","year":"2022","journal-title":"Res. Sq."},{"key":"B10","doi-asserted-by":"publisher","first-page":"18172","DOI":"10.1038\/s41598-023-44598-2","article-title":"Construction of a novel prognostic model in skin cutaneous melanoma based on chemokines-related gene signature","volume":"13","author":"Ding","year":"2023","journal-title":"Sci. Rep."},{"key":"B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1109\/TIPTEKNO.2015.7374558","article-title":"A feature selection analysis in breast cancer diagnosis","volume-title":"2015 medical technologies national conference (TIPTEKNO)","author":"Esener","year":"2015"},{"key":"B12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12859-017-1559-2","article-title":"Reactome pathway analysis: a high-performance in-memory approach","volume":"18","author":"Fabregat","year":"2017","journal-title":"BMC Bioinforma."},{"key":"B13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbrc.2022.01.128","article-title":"MS4A15 acts as an oncogene in ovarian cancer through reprogramming energy metabolism","volume":"598","author":"Fang","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1016\/j.celrep.2017.10.052","article-title":"Genetic and genomic characterization of 462 melanoma patient-derived xenografts, tumor biopsies, and cell lines","volume":"21","author":"Garman","year":"2017","journal-title":"Cell Rep."},{"key":"B15","doi-asserted-by":"publisher","first-page":"19828","DOI":"10.1038\/s41598-024-67562-0","article-title":"Integrating cat boost algorithm with triangulating feature importance to predict survival outcome in recurrent cervical cancer","volume":"14","author":"Geeitha","year":"2024","journal-title":"Sci. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.2147\/CCID.S410723","article-title":"Construction and identification of an NLR-Associated Prognostic signature revealing the heterogeneous immune response in skin cutaneous Melanoma","volume":"16","author":"Geng","year":"2023","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10994-006-6226-1","article-title":"Extremely randomized trees","volume":"63","author":"Geurts","year":"2006","journal-title":"Mach. Learn."},{"key":"B18","doi-asserted-by":"publisher","first-page":"7857","DOI":"10.1038\/srep07857","article-title":"Cancer systems biology of TCGA SKCM: efficient detection of genomic drivers in melanoma","volume":"5","author":"Guan","year":"2015","journal-title":"Sci. Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1023\/A:1012487302797","article-title":"Gene selection for cancer classification using support vector machines","volume":"46","author":"Guyon","year":"2002","journal-title":"Mach. Learn."},{"key":"B20","doi-asserted-by":"publisher","first-page":"107591","DOI":"10.1016\/j.compbiomed.2023.107591","article-title":"Identifying biomarkers associated with immunotherapy response in melanoma by multi-omics analysis","volume":"167","author":"He","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13148-020-00867-9","article-title":"BTB\/POZ zinc finger protein ZBTB16 inhibits breast cancer proliferation and metastasis through upregulating ZBTB28 and antagonizing BCL6\/ZBTB27","volume":"12","author":"He","year":"2020","journal-title":"Clin. Epigenetics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"10732748211051554","DOI":"10.1177\/10732748211051554","article-title":"The identification of Prognostic and metastatic alternative splicing in skin cutaneous Melanoma","volume":"29","author":"Huang","year":"2022","journal-title":"Cancer control."},{"key":"B23","first-page":"772","article-title":"GBP2 is a favorable prognostic marker of skin cutaneous melanoma and affects its progression via the Wnt\/\u03b2-catenin pathway","volume":"51","author":"Ji","year":"2021","journal-title":"Ann. Clin. Lab. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12920-021-00923-0","article-title":"Screening of gene markers related to the prognosis of metastatic skin cutaneous melanoma based on Logit regression and survival analysis","volume":"14","author":"Jia","year":"2021","journal-title":"BMC Med. Genomics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"102358","DOI":"10.1016\/j.pmedr.2023.102358","article-title":"Diabetes risk prediction model based on community follow-up data using machine learning","volume":"35","author":"Jiang","year":"2023","journal-title":"Prev. Med. Rep."},{"key":"B26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/s0190-9622(79)70018-1","article-title":"Photoprotection by melanin--a comparison of black and Caucasian skin","volume":"1","author":"Kaidbey","year":"1979","journal-title":"J. Am. Acad. Dermatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1172\/JCI123955","article-title":"Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells","volume":"129","author":"Kamiya","year":"2019","journal-title":"J. Clin. Invest."},{"key":"B28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jbi.2015.11.012","article-title":"Stabilizing l1-norm prediction models by supervised feature grouping","volume":"59","author":"Kamkar","year":"2016","journal-title":"J. Biomed. Inf."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3315\/jdcr.2014.1161","article-title":"Modern non-invasive diagnostic techniques in the detection of early cutaneous melanoma","volume":"8","author":"Kardynal","year":"2014","journal-title":"J. Dermatol. Case Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1186\/s12885-022-10079-4","article-title":"Pan-cancer analysis of genomic and transcriptomic data reveals the prognostic relevance of human proteasome genes in different cancer types","volume":"22","author":"Larsson","year":"2022","journal-title":"BMC Cancer"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-3245439\/v1","article-title":"Deciphering the prognostic and therapeutic effects of ion channel genes in the occurrence and progression in SKCM","author":"Li","year":"2023"},{"key":"B32","doi-asserted-by":"publisher","first-page":"830570","DOI":"10.3389\/fonc.2022.830570","article-title":"MSLN correlates with immune infiltration and chemoresistance as a prognostic biomarker in ovarian cancer","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"100101","DOI":"10.1016\/j.slast.2023.08.001","article-title":"Identification of m6A-related lncRNAs-based signature for predicting the prognosis of patients with skin cutaneous melanoma","volume":"29","author":"Lin","year":"2024","journal-title":"SLAS Technol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e29655","DOI":"10.1016\/j.heliyon.2024.e29655","article-title":"Pan-cancer analysis of SLC2A family genes as prognostic biomarkers and therapeutic targets","volume":"10","author":"Liu","year":"2024","journal-title":"Heliyon"},{"key":"B35","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1158\/2159-8290.CD-19-0069","article-title":"Combined MAPK pathway and HDAC inhibition breaks melanoma","volume":"9","author":"Lombard","year":"2019","journal-title":"Cancer Discov."},{"key":"B36","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/bib\/bbn027","article-title":"Penalized feature selection and classification in bioinformatics","volume":"9","author":"Ma","year":"2008","journal-title":"Brief. Bioinform."},{"key":"B37","doi-asserted-by":"publisher","first-page":"e33930","DOI":"10.1016\/j.heliyon.2024.e33930","article-title":"Prognostic model development and clinical correlation of eight key genes in skin cutaneous melanoma","volume":"10","author":"Ma","year":"2024","journal-title":"Heliyon"},{"key":"B38","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.semcancer.2019.08.002","article-title":"Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment","volume":"59","author":"Marzagalli","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1593\/neo.09768","article-title":"A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin","volume":"11","author":"Merighi","year":"2009","journal-title":"Neoplasia"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.18632\/aging.205225","article-title":"Potential prognosis and immunotherapy predictor TFAP2A in pan-cancer","volume":"16","author":"Niu","year":"2024","journal-title":"Aging (Albany. NY)"},{"key":"B41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1109\/ESCI53509.2022.9758356","article-title":"RFE-ACO-RF: an approach for cancer microarray data diagnosis","volume-title":"2022 international conference on emerging smart computing and informatics (ESCI)","author":"Panda","year":"2022"},{"key":"B42","first-page":"2825-","article-title":"Scikit-learn: Machine Learning in {P}ython","volume":"12","author":"Pedregosa","year":"2011","journal-title":"J. Mach. Learn. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1002\/cam4.4706","article-title":"Identification and validation of a ferroptosis-related gene signature for predicting survival in skin cutaneous melanoma","volume":"11","author":"Ping","year":"2022","journal-title":"Cancer Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"635488","DOI":"10.3389\/fonc.2021.635488","article-title":"Cutaneous Melanoma classification: the importance of high-throughput genomic technologies","volume":"11","author":"Scatena","year":"2021","journal-title":"Front. Oncol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3390\/cancers13030511","article-title":"Xanthohumol, a prenylated chalcone derived from hops, inhibits growth and metastasis of Melanoma cells","volume":"13","author":"Seitz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.3390\/cancers14143523","article-title":"Conjoined Genes as common events in Childhood Acute lymphoblastic leukemia","volume":"14","author":"Severgnini","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"Ca. Cancer J. Clin."},{"key":"B48","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2174\/1874471012666191015101410","article-title":"Ileal Melanoma, A rare cause of small bowel obstruction: report of a case, and short literature review","volume":"13","author":"Sinagra","year":"2020","journal-title":"Curr. Radiopharm."},{"key":"B49","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1158\/0008-5472.CAN-20-2151","article-title":"Misannotated multi-nucleotide variants in public cancer genomics datasets lead to inaccurate mutation calls with significant implications","volume":"81","author":"Srinivasan","year":"2021","journal-title":"Cancer Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fgene.2019.00292","article-title":"Identification of long non-coding and Messenger RNAs differentially expressed between primary and metastatic Melanoma","volume":"10","author":"Sun","year":"2019","journal-title":"Front. Genet."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1171047","DOI":"10.3389\/fcell.2023.1171047","article-title":"Bioinformatics-based analysis reveals elevated CYTL1 as a potential therapeutic target for BRAF-mutated melanoma","volume":"11","author":"Tao","year":"2023","journal-title":"Front. cell Dev. Biol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ymeth.2023.06.012","article-title":"A multi-platform normalization method for meta-analysis of gene expression data","volume":"217","author":"Tihagam","year":"2023","journal-title":"Methods"},{"key":"B53","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.det.2018.08.003","article-title":"Updates in Melanoma","volume":"37","author":"Tracey","year":"2019","journal-title":"Dermatol. Clin."},{"key":"B54","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3892\/ol.2020.12349","article-title":"MicroRNA-633 enhances melanoma cell proliferation and migration by suppressing KAI1","volume":"21","author":"Wang","year":"2021","journal-title":"Oncol. Lett."},{"key":"B55","doi-asserted-by":"publisher","first-page":"448","DOI":"10.21037\/atm-22-1163","article-title":"Identification of significant genes with a poor prognosis in skin cutaneous malignant melanoma based on a bioinformatics analysis","volume":"10","author":"Wang","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1024931","DOI":"10.3389\/fimmu.2022.1024931","article-title":"Molecular profiling of core immune-escape genes highlights LCK as an immune-related prognostic biomarker in melanoma","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e0298469","DOI":"10.1371\/journal.pone.0298469","article-title":"Pan-cancer analysis of PSCA that is associated with immune infiltration and affects patient prognosis","volume":"19","author":"Wang","year":"2024","journal-title":"PLoS One"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/iid3.468","article-title":"Identification and validation of immune-related lncRNA prognostic signatures for melanoma","volume":"9","author":"Xiao","year":"2021","journal-title":"Immun. Inflamm. Dis."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1111\/jcmm.15015","article-title":"Prognostic value of the expression of chemokines and their receptors in regional lymph nodes of melanoma patients","volume":"24","author":"Xiong","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"570654","DOI":"10.3389\/fonc.2020.570654","article-title":"Prognostic role of tumor mutation burden combined with immune infiltrates in skin cutaneous melanoma based on multi-omics analysis","volume":"10","author":"Yan","year":"2020","journal-title":"Front. Oncol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/2909095","article-title":"The critical gene screening to prevent chromophobe cell renal carcinoma metastasis through TCGA and WGCNA","volume":"2022","author":"Yan","year":"2022","journal-title":"J. Oncol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"10990","DOI":"10.1111\/jcmm.17021","article-title":"Identification of a novel tumour microenvironment-based prognostic biomarker in skin cutaneous melanoma","volume":"25","author":"Yang","year":"","journal-title":"J. Cell. Mol. Med."},{"key":"B63","doi-asserted-by":"publisher","first-page":"795427","DOI":"10.3389\/fmed.2021.795427","article-title":"LncRNA MSC-AS1 is a diagnostic biomarker and predicts poor prognosis in patients with gastric cancer by integrated bioinformatics analysis","volume":"8","author":"Yang","year":"","journal-title":"Front. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"107089","DOI":"10.1016\/j.compbiomed.2023.107089","article-title":"Machine learning modeling and prognostic value analysis of invasion-related genes in cutaneous melanoma","volume":"162","author":"Yang","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-970091\/v1","article-title":"Bioinformatics analysis of ISLR in pan-cancer and its correlation with tumor immunity","author":"Zhang","year":"","journal-title":"Res. Sq."},{"key":"B66","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1038\/s41598-021-84465-6","article-title":"B2M overexpression correlates with malignancy and immune signatures in human gliomas","volume":"11","author":"Zhang","year":"","journal-title":"Sci. Rep."},{"key":"B67","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.ajpath.2023.03.016","article-title":"Transcriptome analysis identifies oncogenic tissue remodeling during progression from common Nevi to early melanoma","volume":"193","author":"Zia","year":"2023","journal-title":"Am. J. Pathol."}],"container-title":["Frontiers in Bioinformatics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2025.1624329\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:53:15Z","timestamp":1767768795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbinf.2025.1624329\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":67,"alternative-id":["10.3389\/fbinf.2025.1624329"],"URL":"https:\/\/doi.org\/10.3389\/fbinf.2025.1624329","relation":{},"ISSN":["2673-7647"],"issn-type":[{"value":"2673-7647","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"article-number":"1624329"}}